Author

admin

Browsing

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), today announced that it has completed its trial entitled “A Phase 1, Randomised, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study to Evaluate the Safety and Pharmacokinetics of Lucid-21-302 in Healthy Adult Participants.” A final safety review committee…

Bitcoin is prone to price volatility, with wide swings to the upside and downside. There has been renewed interest in cryptocurrencies following the election of US President Donald Trump. The Bitcoin price, after soaring to new heights in 2024, has consolidated just under US$100,000 in the first quarter of 2025…